# Carboplatin and Etoposide With or Without Thalidomide in Treating Patients With Limited-Stage or Extensive-Stage Small Cell Lung Cancer

> **NCT00061919** · PHASE3 · COMPLETED · sponsor: **University College, London** · enrollment: 724 (actual)

## Conditions studied

- Lung Cancer

## Interventions

- **DRUG:** Carboplatin, etoposide & thalidomide
- **DRUG:** Carboplatin, etoposide & placebo

## Key facts

- **NCT ID:** NCT00061919
- **Lead sponsor:** University College, London
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2003-04
- **Primary completion:** 2007-02
- **Final completion:** 2007-07
- **Target enrollment:** 724 (ACTUAL)
- **Last updated:** 2012-03-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00061919

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00061919, "Carboplatin and Etoposide With or Without Thalidomide in Treating Patients With Limited-Stage or Extensive-Stage Small Cell Lung Cancer". Retrieved via AI Analytics 2026-06-05 from https://api.ai-analytics.org/clinical/NCT00061919. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*